Literature DB >> 7600657

Metabolic adaptation to a gradual reduction in myocardial blood flow.

A E Arai1, S E Grauer, C G Anselone, G A Pantely, J D Bristow.   

Abstract

BACKGROUND: Studies during 20% to 50% reductions in regional coronary blood flow have revealed a number of metabolic and functional adaptations that suggest the heart downregulates energy requirements and contractility in response to ischemia. In contrast to prior studies of sudden changes in coronary blood flow, we tested whether the heart could reduce ATP consumption commensurate with a gradual decrease in coronary blood flow or whether transient metabolic abnormalities are a necessary trigger in this process. METHODS AND
RESULTS: From 0 to 35 minutes, mean left anterior descending coronary artery blood flow was reduced by approximately 1% per minute in 10 acutely anesthetized and instrumented swine. Coronary blood flow then was held constant between 35 and 60 minutes at the resulting 35% net blood flow reduction. Although systemic hemodynamics remained stable, a significant decrease in regional left ventricular systolic wall thickening developed (from control value of 45 +/- 11% to 18 +/- 11% at 60 minutes, P < .001) without a sustained decrease in the phosphorylation potential (as assessed by a < 2% decrease in either the transmural or subendocardial phosphocreatine-to-ATP ratio) and with minimal myocardial lactate production (4 +/- 44 mumol.min-1 x 100 g-1).
CONCLUSIONS: Metabolic markers of ischemia such as ratio of phosphocreatine to ATP, ATP content, lactate content, and lactate production were blunted during this protocol of gradually worsening ischemia. Thus, contractile abnormalities of mild ischemia can develop with minimal metabolic evidence of ischemia. The downregulation of myocardial energy requirements can almost keep pace with the gradual decline in coronary blood flow.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7600657     DOI: 10.1161/01.cir.92.2.244

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

1.  Glucose metabolism distal to a critical coronary stenosis in a canine model of low-flow myocardial ischemia.

Authors:  P H McNulty; A J Sinusas; C Q Shi; D Dione; L H Young; G C Cline; G I Shulman
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Computer-aided analysis of biochemical mechanisms that increase metabolite and proton stability in the heart during severe hypoxia and generate post-ischemic PCr overshoot.

Authors:  Bernard Korzeniewski
Journal:  J Physiol Sci       Date:  2011-06-11       Impact factor: 2.781

Review 3.  Hypoxia. 2. Hypoxia regulates cellular metabolism.

Authors:  William W Wheaton; Navdeep S Chandel
Journal:  Am J Physiol Cell Physiol       Date:  2010-12-01       Impact factor: 4.249

4.  An isolated perfused pig heart model for the development, validation and translation of novel cardiovascular magnetic resonance techniques.

Authors:  Andreas Schuster; Inga Grünwald; Amedeo Chiribiri; Richard Southworth; Masaki Ishida; Gunnar Hay; Nicole Neumann; Geraint Morton; Divaka Perera; Tobias Schaeffter; Eike Nagel
Journal:  J Cardiovasc Magn Reson       Date:  2010-09-17       Impact factor: 5.364

Review 5.  Features of short-term myocardial hibernation.

Authors:  G Heusch; R Schulz
Journal:  Mol Cell Biochem       Date:  1998-09       Impact factor: 3.396

Review 6.  Assessment of myocardial viability with two-dimensional echocardiography and magnetic resonance imaging.

Authors:  J R Lindner; S Kaul
Journal:  J Nucl Cardiol       Date:  1996 Mar-Apr       Impact factor: 5.952

Review 7.  Myocardial stunning and hibernation revisited.

Authors:  Gerd Heusch
Journal:  Nat Rev Cardiol       Date:  2021-02-02       Impact factor: 32.419

Review 8.  A pathophysiological compass to personalize antianginal drug treatment.

Authors:  Edoardo Bertero; Gerd Heusch; Thomas Münzel; Christoph Maack
Journal:  Nat Rev Cardiol       Date:  2021-07-07       Impact factor: 32.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.